A collaborative culture brings together HJP’s team members with diverse background. Our team has a blend of experience in scientific prowess, strategic operations, macro understanding and financial acumen. Our team brings a combination of investment and industry expertise, offering deep industry insights, a global perspective, and a proven track record of diversified investment experience.

Our Venture Partners collectively bring over 500 years of combined expertise across Medtech and Biotechnology, with deep roots in pioneering innovation and scaling ventures. Primarily based in the US and Europe, they offer global perspectives honed through leadership roles at top-tier organizations such as Alnylam, Pfizer, Novartis, Abbott, and Bio-Techne. Their specialties span RNAi therapeutics, viral & non-viral gene therapy, biologics/CGT development, medical devices, cross-border M&A, regulatory, and corporate strategy. Our venture partners also bring alongside decades of entrepreneurial success in founding, growing, and exiting startups. This network of seasoned experts enhances HJP’s ability to identify transformative opportunities, navigate complex markets, and drive value creation across our portfolio.